| Literature DB >> 31839775 |
Magdalena Wawrzynkiewicz1, Maciej Pastuszczak1, Michał Chlebicki2, Anna Wojas-Pelc1.
Abstract
INTRODUCTION: Acral melanocytic nevi dermoscopic patterns have been well described in several populations. There have been no prospective studies assessing the prevalence, clinical characteristics and dermoscopic patterns of acral nevi in the Polish population. AIM: To characterize the prevalence of acral nevi, frequency of dermoscopic patterns, relationships between acral nevi and patients' characteristics.Entities:
Keywords: acral nevi; dermoscopic patterns; dermoscopy; prevalence
Year: 2019 PMID: 31839775 PMCID: PMC6906974 DOI: 10.5114/ada.2018.77500
Source DB: PubMed Journal: Postepy Dermatol Alergol ISSN: 1642-395X Impact factor: 1.837
Patients’ characteristics, skin phototype, nevi characteristics, personal and family history
| Parameter | Number (%) |
|---|---|
| Total number of patients | 713 (100) |
| Total number of patients with an acral nevus | 287 (40.2) |
| Women: | |
| Age: median 40 y (34–54); mean 43.5 ±13.2y | 174 (60.6) |
| Men: | |
| Age: median 40 y (34–48); mean 42.8 ±13.1y | 113 (39.4) |
| Education: | |
| Higher | 187 (66.1) |
| Secondary | 82 (29) |
| Primary | 14 (4.9) |
| Place of living: | |
| City (> 50 000 inhabitants) | 224 (78) |
| Countryside | 63 (22) |
| Fitzpatrick skin phototype: | |
| I | 19 (6.6) |
| II | 168 (58.5) |
| III | 93 (32.4) |
| IV | 7 (2.4) |
| Number of patients with: | |
| > 100 nevi on the body | 115 (40.1) |
| 50–100 nevi on the body | 98 (34.1) |
| 20–50 nevi on the body | 74 (25.8) |
| Atypical nevi on the body | 247 (86.1) |
| Congenital nevi on the body | 140 (48.8) |
| Previous melanoma excision | 50 (17.4) |
| Previous dysplastic nevus excision | 100 (34.8) |
| Melanoma in family (first-, second-degree relatives) | 48 (16.7) |
Dermoscopic patterns of acral nevi
| Dermoscopic pattern | Soles Number (%) | Palms Number (%) | Total Number (%) |
|---|---|---|---|
| Parallel furrow: | 145 (33.4) | 117 (61.6) | 262 (42) |
| Single line | 87 (20) | 69 (36.3) | 156 (25) |
| Double line | 8 (1.8) | 1 (0.5) | 9 (1.4) |
| Single dotted line | 47 (10.8) | 34 (18) | 81 (13) |
| Double dotted line | 3 (0.69) | 13 (6.8) | 16 (2.6) |
| Lattice-like pattern | 62 (14.3) | 44 (23.2) | 106 (17) |
| Fibrillar | 66 (15.2) | 0 (0) | 66 (11) |
| Other: | 161 (37.1) | 29 (15.3) | 190 (30) |
| Globular | 17 (3.9) | 13 (6.8) | 30 (4.8) |
| Homogenous | 9 (2.1) | 4 (2.1) | 13 (2.1) |
| Reticular | 10 (2.3) | 2 (1.1) | 12 (1.9) |
| Non-typical | 102 (23.5) | 10 (5.3) | 112 (18) |
| Parallel ridge pattern | 3 (0.7) | 0 (0) | 3 (0.5) |
| Multi-component | 20 (4.6) | 0 (0) | 20 (3.2) |
Location and dermoscopic patterns of acral nevi
| Soles | Dermoscopic pattern | |||||
|---|---|---|---|---|---|---|
| Other ( | Lattice-like ( | Parallel furrow ( | Fibrillar ( | |||
| Location | Other ( | 102 (41.1%) | 24 (9.7%) | 117 (47.2%) | 5 (2.0%) | < 0.001 |
| Arch ( | 35 (40.7%) | 35 (40.7%) | 15 (17.4%) | 1 (1.2%) | ||
| Weight-bearing area ( | 24 (24%) | 3 (3%) | 13 (13%) | 60 (60%) | ||
| Diameter [mm] | Mean ± SD Me (Q1–Q3) | 4.54 ±2.24 4.1 (3–5.7) | 3.49 ±1.48 3.15 (2.4–4.38) | 3.78 ±2.12 3.2 (2.2–4.55) | 3.78 ±1.5 3.43 (2.7–4.55) | < 0.001 |
| Location | Palm ( | 15 (11.5%) | 29 (22.3%) | 86 (66.2%) | 0.072 | |
| Fingers ( | 14 (23.3%) | 15 (25%) | 31 (51.7%) | |||
| Diameter [mm] | Mean ± SD Me (Q1–Q3) | 2.34 ±1.17 2.20 (1.70–2.6) | 2.27 ±1.11 2.10 (1.53–2.7) | 2.42 ±1.27 2.10 (1.50–3.10) | 0.837 | |
Location of acral nevi
| Parameter | Soles ( | Palms ( | Soles AND palms ( | Soles AND/OR palms ( | |
|---|---|---|---|---|---|
| Women/men | 94/70 57.3%/42.7% | 27/17 61.4%/38.6% | 53/26 67.1%/32.9% | 174/113 60.6%/39.4% | 0.345 |
| Age [years]: | |||||
| Mean ± SD | 45 ±13.1 | 40.4 ±13.4 | 41.1 ±12.67 | 43.2 ±13.15 | 0.029 |
| Median (Q1–Q3) | 41 (35–57) | 38 (31–45) | 38 (33–46) | 40 (34–52) | |
| Fitzpatrick: | 0.926 | ||||
| I + II | 106 (64.6%) | 27 (61.4%) | 54 (68.4%) | 187 (65.1%) | |
| III + IV | 58 (35.4%) | 17 (38.6%) | 25 (37.7%) | 100 (34.8%) | |
| Presence of atypical nevi on the body | 140 (85.4%) | 36 (81.8%) | 719 (89.9%) | 247 (86.1%) | 0.431 |
| Presence of congenital nevi on the body | 79 (48.2%) | 16 (36.4%) | 45 (57%) | 140 (48.8%) | 0.088 |
| Total body nevi count: | |||||
| B 20–50 | B 43 (26.2%) | B 15 (34.1%) | B 16 (20.3%) | B 74 (25.8%) | 0.043 |
| C 50–100 | C 55 (33.5%) | C 18 (40.9%) | C 25 (31.7%) | C 98 (34.1%) | |
| D > 100 | D 66 (40.2%) | D 11 (25%) | D 38 (48.1%) | D 115 (40.1%) | |
| Melanoma removal | 31 (18.9%) | 7 (15.9%) | 12 (15.2%) | 50 (17.4%) | 0.743 |
| Dysplastic nevi removal | 54 (32.9%) | 17 (38.6%) | 29 (36.7%) | 100 (34.8%) | 0.717 |
| Number of atypical nevi: | 0.011 | ||||
| Mean | 3.01 | 2.5 | 3.6 | 3.1 | |
| Median | 3 | 2 | 3 | 3 | |
| Number of acral nevi: | < 0.001 | ||||
| Mean | 1.8 | 1.4 | 3.3 | 2.2 | |
| Median | 1 | 1 | 3 | 2 |
Number of acral nevi and number of atypical nevi on the body
| Number of acral nevi | Number of atypical nevi on the body | |||
|---|---|---|---|---|
| 0 ( | 1–4 ( | ≥ 5 ( | ||
| Mean ± SD | 1.8 ±1.11 | 2.07 ±1.33 | 2.94 ±1.67 | 0.001 |
| Median (Q1–Q3): | 1 (1–3) | 2 (1–3) | 2.5 (2–4) | |
| ≥ 3 ( | 11 (12.5%) | 53 (60.2%) | 24 (27.3%) | 0.006 |
| 1–2 ( | 29 (14.6%) | 146 (73.4%) | 24 (12.1%) | |
Comparison of results of research on acral melanocytic lesions
| Parameter | Saida | Malvehy | Miyazaki | Altamura | Ozdermir | Kokgil | Barquet | Madankumar | Wawrzynkiewicz | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total number of patients | Unknown | 511 | 278 | 641 | 2625 | 295 | 80 | 1052 | 713 | |
| Number of patients with acral lesions | Unknown | 156 (30.5%) | 278 | 641 | 138 (5.3%) | 295 | 80 | 379 (36%) | 287 (40%) | |
| Age – mean (min.–max.) | NE | 34 (15–67) | 26.9 (0–79) | 28.8 (0.5–73) | 29 (10–65) | 31.8 (5–86) | 36.6 (> 18) | 49.6 (18–96) | 43 (18–81) | |
| Gender | NE | W 67.1% M 32.9% | W 59.4% M 40.6% | W 63.4% M 36.6% | W 81% M 57% | W 67.8% M 32.2% | W 76.3% M 23.7% | W 59% M 41% | W 60.6% M 39.4% | |
| Fitzpatrick skin phototype | NE | NE | NE | I 0.8% | I 0 | NE | I 0 | I–II 41% | I 6.6% | |
| Number of acral lesions | ||||||||||
| Average diameter of acral lesions [mm] | NE | NE | NE | NE | 3 (1–10) | 2.66 (0.68–20) | 2.5 | NE | 3.5 (07–12.3) | |
| Dermoscopic patterns of acral lesions: | Parallel furrow | 292 (47.9%) | 111 (52.8%) | 103 (34.5%) | 304 (42.1%) | 110 (58.5%) | 262 (62.5%) | 81 (51.3%) | 280 (44.7%) | 262 (42%) |
| Lattice–like | 117 (19.9%) | 26 (12.4%) | 64 (21.5%) | 108 (14.9%) | 12 (6.4%) | 18 (4.3%) | 21 (13.3%) | 89 (14.2%) | 106 (17%) | |
| Fibrillar | 147 (24.1%) | 13 (6.2%) | 131 (43.9%) | 78 (10.8%) | 23 (12.2%) | 21 (5.0%) | 11 (7%) | 51 (8.1%) | 66 (11%) | |
| Homogenous | NE | 15 (7.1%) | NE | 67 (9.3%) | 12 (6.4%) | 16 (3.8%) | 20 (12.7%) | 59 (9.4%) | 13 (2.1%) | |
| Globular | NE | 11 (5.2%) | NE | 39 (5.4%) | 4 (2.1%) | 32 (7.6%) | 15 (9.5%) | 39 (6.2%) | 30 (4.8%) | |
| Reticular | NE | 5 (2.4%) | NE | 15 (2.1%) | 8 (4.3%) | 51 (12.2%) | 0 | 12 (1.9%) | ||
| Non-typical | NE | 29 (13.8%) | NE | 99 (13.7%) | 6 (3.2%) | 16 (3.8%) | 4 (2.5%) | 112 (18%) | ||
| Transition | NE | NE | NE | 13 (1.8%) | NE | NE | 0 | 0 | ||
| Globulostreak-like | NE | NE | NE | NE | 10 (5.3%) | 2 (0.5%) | 6 (3.8) | 0 | ||
| Parallel ridge pattern | 6 (1%) | 0 | NE | 0 | 3 (1.6%) | 1 (0.2%) | NE | 2 (0.3%) | 3 (0.5%) | |
| Multi-component | NE | 0 | NE | 0 | 0 | NE | 0 | 20 (3.2%) | ||
| Diffuse irregular pigmentation | 21 (3.4%) | NE | NE | NE | NE | NE | 0 | 0 | ||
NE – not evaluated, W – women, M – men.